Cross Town News
Cross Town News India Follow Editor Rahil Gupta on   Twitter   Instagram

Biological E gets nod for phase 2/3 clinical trial for vaccine on children


Cinosural International An Elementry School Jammu

New Delhi, September 3:  The Department of Biotechnology (DBT) said on Friday that Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents.

Corbevax, an BD protein sub-unit vaccine, has been developed with supported from the Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council (BIRAC), it said.

 

 


   Popular News

Top